1. Home
  2. DARE vs CVM Comparison

DARE vs CVM Comparison

Compare DARE & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DARE
  • CVM
  • Stock Information
  • Founded
  • DARE N/A
  • CVM 1983
  • Country
  • DARE United States
  • CVM United States
  • Employees
  • DARE N/A
  • CVM N/A
  • Industry
  • DARE Biotechnology: Pharmaceutical Preparations
  • CVM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • DARE Health Care
  • CVM Health Care
  • Exchange
  • DARE Nasdaq
  • CVM Nasdaq
  • Market Cap
  • DARE 31.9M
  • CVM 35.7M
  • IPO Year
  • DARE N/A
  • CVM 1987
  • Fundamental
  • Price
  • DARE $3.21
  • CVM $0.56
  • Analyst Decision
  • DARE Strong Buy
  • CVM
  • Analyst Count
  • DARE 4
  • CVM 0
  • Target Price
  • DARE $20.33
  • CVM N/A
  • AVG Volume (30 Days)
  • DARE 64.6K
  • CVM 459.4K
  • Earning Date
  • DARE 11-14-2024
  • CVM 12-19-2024
  • Dividend Yield
  • DARE N/A
  • CVM N/A
  • EPS Growth
  • DARE N/A
  • CVM N/A
  • EPS
  • DARE N/A
  • CVM N/A
  • Revenue
  • DARE $1,881,316.00
  • CVM N/A
  • Revenue This Year
  • DARE $388.48
  • CVM N/A
  • Revenue Next Year
  • DARE $67.37
  • CVM $3,412.81
  • P/E Ratio
  • DARE N/A
  • CVM N/A
  • Revenue Growth
  • DARE 88.13
  • CVM N/A
  • 52 Week Low
  • DARE $3.05
  • CVM $0.54
  • 52 Week High
  • DARE $7.56
  • CVM $3.23
  • Technical
  • Relative Strength Index (RSI)
  • DARE 36.32
  • CVM 14.93
  • Support Level
  • DARE $3.42
  • CVM $0.54
  • Resistance Level
  • DARE $4.60
  • CVM $0.92
  • Average True Range (ATR)
  • DARE 0.32
  • CVM 0.06
  • MACD
  • DARE -0.09
  • CVM -0.02
  • Stochastic Oscillator
  • DARE 2.11
  • CVM 5.18

About DARE Dare Bioscience Inc.

Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

About CVM Cel-Sci Corporation

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company's core capabilities that include are drug discovery, research, development and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

Share on Social Networks: